Aims and scope

BMJ Leader is an international, peer-reviewed, online only, subscription based journal that publishes articles in the field of healthcare leadership. With a focus on original research and reviews, the journal is a place of discussion and debate for the many disciplines that make up leadership in the health services.

BMJ Leader is the official journal of the Faculty of Medical Leadership and Management.


BMJ Leader is co-owned by BMJ and the Faculty of Medical Leadership and Management.

Editorial Board

For information about BMJ Leader’s Editor Dr James Mountford and the editorial team, please refer to the Editorial Board page

Journal information

Publication Model Subscription; with hybrid open access option
Frequency Quarterly
Launch Date 2017
Digital archive LOCKSS
Indexed By Google Scholar, Scopus
Peer Review Model Single blind; the names of reviewers are hidden from the author
Online ISSN 2398-631X

Journal statistics (2018)

Acceptance Rate 68%
Rejection Rate 18%
Time from Submission to First Decision 47 days
Time from Acceptance to Publication 16 days

Contact information

For all contact information please refer to the contact us page.

For Authors

Please refer to the Instructions for authors


To advertise

Rights and permissions


FMLM logo

The Faculty of Medical Leadership and Management is the UK professional home for medical leadership. Its primary objective is to raise the standard of patient care by improving medical leadership.

COPE logo

BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.


The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.